An Escherichia coli isolate from hospital sewage carries blaNDM-1 and blaoxa-10

Arch Microbiol. 2021 Sep;203(7):4427-4432. doi: 10.1007/s00203-021-02431-2. Epub 2021 Jun 15.

Abstract

Carbapenems, as the "last line of defense" against Gram-negative bacteria, are increasingly being challenged by drug-resistant bacteria, especially Enterobacteriaceae. In this study, a carbapenem-resistant Gram-negative bacterium, named AH001, was isolated from hospital sewage, and a modified Hodge test confirmed that this bacterium can produce carbapenemase. Further analysis revealed that this bacterium exhibits multidrug resistance against an additional seven antibiotics. Whole-genome sequencing and analysis showed that AH001 could not be classified by existing MLST, and its serotype could not be distinguished among O9, O89 or O168 according to O antigen prediction. More attention should be given to the role of environmental sources of Escherichia coli in the development and transfer of drug resistance in the hospital environment.

Keywords: Bla NDM-1; Bla OXA-10; Carbapenemase; Environmental bacteria; Escherichia coli.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / genetics
  • Carbapenem-Resistant Enterobacteriaceae* / genetics
  • Enterobacteriaceae* / drug effects
  • Enterobacteriaceae* / enzymology
  • Enterobacteriaceae* / genetics
  • Escherichia coli / genetics
  • Hospitals*
  • Microbial Sensitivity Tests
  • Multilocus Sequence Typing
  • Sewage*
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Sewage
  • beta-Lactamases
  • beta-lactamase NDM-1